Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
Finance Home
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
7,859.74
+23.03
(+0.29%)
FTSE 250
20,193.36
-216.02
(-1.06%)
AIM
879.41
-4.38
(-0.50%)
GBP/EUR
1.1232
+0.0026
(+0.23%)
GBP/USD
1.2012
-0.0012
(-0.10%)
BTC-GBP
19,132.66
-163.64
(-0.85%)
Shield Therapeutics plc (STX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
6.30
-0.10
(-1.56%)
At close: 03:40PM GMT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in GBP.
All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,069
1,519
10,387
719
Cost of revenue
1,454
980
1,354
485
Gross profit
1,615
539
9,033
234
Operating expenses
Research development
7
579
2,579
2,496
Selling general and administrative
23,752
17,816
5,903
4,152
Total operating expenses
25,648
20,491
11,187
9,269
Operating income or loss
-24,033
-19,952
-2,154
-9,035
Interest expense
-3
0
0
1
Income before tax
-23,410
-19,565
-1,886
-9,066
Income tax expense
425
-229
744
-266
Income from continuing operations
-23,835
-19,336
-2,630
-8,800
Net income
-23,835
-19,336
-2,630
-8,800
Net income available to common shareholders
-23,835
-19,336
-2,630
-8,800
Basic EPS
-
-0.09
-0.02
-0.08
Diluted EPS
-
-0.09
-0.02
-0.08
Basic average shares
-
221,163
120,682
120,428
Diluted average shares
-
221,163
120,682
120,428
EBITDA
-
-17,358
819
-6,444
© 2023 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About our ads